Marshall Wace North America’s Exact Sciences EXAS Stock Holding History

Marshall Wace North America’s Portfolio EXAS Stock Details EXAS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	$979K	Buy	10,251 +8,459	+472%	+$893K	﹤0.01%	927
2021 Q2	$223K	Sell	1,792 -19,646	-92%	-$2.34M	﹤0.01%	1332
2021 Q1	$2.83M	Buy	21,438 +5,210	+32%	+$713K	0.01%	714
2020 Q4	$2.15M	Buy	+16,228	New	+$1.96M	0.01%	741
2020 Q3	–	Sell	-19,559	Closed	-$1.7M	–	1286
2020 Q2	$1.7M	Buy	19,559 +9,992	+104%	+$798K	0.01%	629
2020 Q1	$555K	Sell	9,567 -349,031	-97%	-$28.3M	﹤0.01%	733
2019 Q4	$33.2M	Buy	+358,598	New	+$31.5M	0.16%	156
2017 Q3	–	Sell	-25,936	Closed	-$908K	–	1330
2017 Q2	$908K	Sell	25,936 -163,926	-86%	-$5.06M	0.01%	958
2017 Q1	$4.56M	Buy	+189,862	New	+$3.76M	0.04%	410

Other funds holding EXAS

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

AIM

ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Marshall Wace North America's EXAS Position: Q3 2021 in Review

Marshall Wace North America increased its Exact Sciences (EXAS) stake by 472% in Q3 2021, buying an estimated $893K and bringing the position to 10,251 shares worth $979K. The position accounts for ﹤0.01% of the portfolio, ranked #927.

Marshall Wace North America first reported a position in EXAS in Q1 2017 and has held it in 9 quarters since. The position peaked at $33.2M in Q4 2019. 602 funds tracked by Wall St. Rank hold EXAS as of Q3 2021.

Marshall Wace North America held 10,251 shares of Exact Sciences worth $979K as of Q3 2021.
Marshall Wace North America bought 8,459 Exact Sciences shares in Q3 2021, an estimated $893K.
Exact Sciences made up ﹤0.01% of Marshall Wace North America's portfolio in Q3 2021, its #927 holding.
Marshall Wace North America first reported a position in Exact Sciences in Q1 2017 and has held it in 9 quarters since.
Marshall Wace North America's Exact Sciences position peaked at $33.2M in Q4 2019.
602 funds tracked by Wall St. Rank held Exact Sciences as of Q3 2021.

Based on Marshall Wace North America's 13F filing for Q3 2021, filed 15 Nov 2021.